canyon landscape

2021 Barrow Pituitary Symposium

Who Should Attend 

Physicians, nurse practitioners, physician’s assistants, nurses and other healthcare professionals with an interest in the application of best practices involving pituitary physiology, pituitary tumors, and other neuro-endocrine disorders.

Objectives 

At the end of this activity, the learner should be able to recommend the appropriate diagnostic modalities for patients with pituitary disorders with subtle clinical findings to ensure early diagnosis and intervention by pituitary specialists, describe the appropriate treatment algorithms for patients with various types of pituitary tumors, select the appropriate medical/hormonal treatment options for pituitary disorders before and after surgery as well as in lieu of surgical intervention, and recognize the  importance of accurate performance of critical diagnostic testing for post-operative  hormonal and electrolyte dysfunction.

Registration Information

Attendee TypeEarly BirdLate registration
Physician$150$200
Resident / Fellow$90$140
NP / PA / RN$90$140
Dignity Health Residents / FellowsWaivedWaived
Dignity Health RN / NPWaivedWaived
Registration fee includes: Symposium, program materials, and continuing education credits.
Refund and cancellation policy: Barrow reserves the right to cancel or change the program for due causes. Cancellation of this program by Barrow or by the participant before October 10th will result in a full refund of tuition.

Continuing Medical Education Credit Information

Accreditation
This activity has been planned and implemented in accordance with the Essential  Areas and Policies of the Accreditation Council for Continuing Medical Education  (ACCME) through the joint providership of the American College of Surgeons and  Dignity Health. The American College of Surgeons is accredited by the ACCME to  provide continuing medical education for physicians. 

AMA PRA Category 1 Credits™
The American College of Surgeons designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit  commensurate with the extent of their participation in the activity.

acs logo
acs logo 2
skull base and pituitary gland

Date, Time, and Location

Saturday, November 6, 2021
8:00 AM to 3:00 PM
Also available online

Goldman Auditorium
Barrow Neurological Institute
2910 North 3rd Avenue
Phoenix, Arizona 85013
Scroll down for campus map

Speaker Information

SPeakerTopic
Registration7:30 AM – 7:55 AM
Kevin Yuen, MDWelcome and Announcements (7:55 AM)
Andrew Little, MDLive Surgery & Case Overview (8:05 AM)
Douglas Hardesty, MDModern Surgical Management of Acromegaly (8:25 AM)
Roberto Salvatori, MDTreatment of Prolactinomas: When, How and How Long? (9:00 AM)
Andrew Little, MDLive Surgery Check In (9:35 AM)
Break9:55 AM – 10:10 AM
Scott Brigeman, MDOutcomes after Surgery for Cushing’s Disease (10:10 AM)
Michael Garcia, MDRadiotherapy for Pituitary Tumors (10:45 AM)
Kevin Yuen, MDPearls of Diagnosis and Management of DI and SIADH (11:20 AM)
Lunch11:55 AM – 12:45 PM
Brian Wilhelmi, MDAnesthesia Considerations in Transsphenoidal Surgery (12:45 PM – concurrent)
Andrew Little, MDAdvances in Pituitary Surgery (12:45 PM – concurrent)
Griffin Santarelli, MDThe Sinonasal Approach and Recovery of Pituitary Surgery (1:20 PM)
Andrew Little, MD
Kevin Yuen, MD
Eva Duran, FNP-C 
Debate with Case Presentations (1:45 PM)
Topics:
How to treat acromegaly with invasion into the cavernous sinus with residual tumor?
Management of complicated post-op complications (DI, SIADH)
Unusual Presentation of Cushing’s or other complex patient
How pathology results influence post-op management
Managing unresectable cases
Andrew Little, MDDeparting Announcements and Adjourn (2:45 PM)
Barrow Neurological Institute campus in 3D

Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any ineligible company held in the last 24 months. Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

Ineligible Company: The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

Financial Relationships: Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

Conflict of Interest: Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.

Disclosures
Planning Committee/Moderators/Speakers
Kevin Yuen, MD
Financial disclosures – Research funding: Corcept, Chiasma, Ascendis, Novartis
Advisory Board/Honorarium: NovoNordisk, Corcept, Recordati, Strongbridge, Chiasma, Ascendis,Ipsen, Rani Therapeutics, Sandoz
Andrew Little, MD 
Financial disclosures –Consultant/Stakeholder: Spiway, Kogent
Consultant: BK Medical
Eva Marie Duran, MSN, FNP-C
Financial disclosures – Honorarium: NovoNordisk
Speakers
Michael Garcia, MD
Financial disclosures – None
Griffin Santarelli, MD
Financial disclosures – None 
Brian Wilhelmi, MD
Financial disclosures – None 
Roberto Salvatori, MD
Financial disclosures – Consultant: Recordati, Ipsen, Strongbridge, HRA Pharma
Scott Brigeman, MD  
Financial disclosures – None
Douglas Hardesty, MD 
Financial disclosures – None